SEPN

Daniel D. Long

Known title: SVP, Drug DiscoveryCIK: 0002040349

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

Septerna Schedules Upcoming Investor Conference Appearances. Septerna announced plans to participate in upcoming investor conferences. Such events are routine for publicly traded companies and provide opportunities for management to engage with institutional investors and analysts. The conferences may include presentations and one-on-one meetings, though no specific details about agenda topics were disclosed.

this person other insiders at SEPN

Transaction History

SEPN▲ Buy$9K
SEPN▼ Sell$126K
SEPN▲ Buy$5K
SEPN▲ Buy$4K
SEPN▼ Sell$34K
SEPN▼ Sell$81K
SEPN▲ Buy$9K
SEPN▼ Sell$72K
SEPN▼ Sell$43K
SEPN▲ Buy$29K
SEPN▲ Buy$52K
SEPN▼ Sell$281K
SEPN▼ Sell$252K
SEPN▼ Sell$63K

We use analytics to understand how market-wall is used. No personal data is sold.